BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1568 related articles for article (PubMed ID: 25863355)

  • 21. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis.
    Ciccarelli O; Wheeler-Kingshott CA; McLean MA; Cercignani M; Wimpey K; Miller DH; Thompson AJ
    Brain; 2007 Aug; 130(Pt 8):2220-31. PubMed ID: 17664178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
    Cawley N; Solanky BS; Muhlert N; Tur C; Edden RA; Wheeler-Kingshott CA; Miller DH; Thompson AJ; Ciccarelli O
    Brain; 2015 Sep; 138(Pt 9):2584-95. PubMed ID: 26304151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
    John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
    J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
    Biberacher V; Boucard CC; Schmidt P; Engl C; Buck D; Berthele A; Hoshi MM; Zimmer C; Hemmer B; Mühlau M
    Mult Scler; 2015 Jun; 21(7):875-84. PubMed ID: 25139943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
    Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
    Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
    Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes.
    Castellano A; Papinutto N; Cadioli M; Brugnara G; Iadanza A; Scigliuolo G; Pareyson D; Uziel G; Köhler W; Aubourg P; Falini A; Henry RG; Politi LS; Salsano E
    Brain; 2016 Jun; 139(Pt 6):1735-46. PubMed ID: 27068048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach.
    Vaithianathar L; Tench CR; Morgan PS; Constantinescu CS
    J Neurol; 2003 Mar; 250(3):307-15. PubMed ID: 12638021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential patterns of spinal cord and brain atrophy in NMO and MS.
    Liu Y; Wang J; Daams M; Weiler F; Hahn HK; Duan Y; Huang J; Ren Z; Ye J; Dong H; Vrenken H; Wattjes MP; Shi FD; Li K; Barkhof F
    Neurology; 2015 Apr; 84(14):1465-72. PubMed ID: 25762714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.
    Rovaris M; Judica E; Gallo A; Benedetti B; Sormani MP; Caputo D; Ghezzi A; Montanari E; Bertolotto A; Mancardi G; Bergamaschi R; Martinelli V; Comi G; Filippi M
    Brain; 2006 Oct; 129(Pt 10):2628-34. PubMed ID: 16921179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
    Kearney H; Rocca MA; Valsasina P; Balk L; Sastre-Garriga J; Reinhardt J; Ruggieri S; Rovira A; Stippich C; Kappos L; Sprenger T; Tortorella P; Rovaris M; Gasperini C; Montalban X; Geurts JJ; Polman CH; Barkhof F; Filippi M; Altmann DR; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2014 Jan; 20(1):72-80. PubMed ID: 23812283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
    de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
    Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
    Laule C; Vavasour IM; Zhao Y; Traboulsee AL; Oger J; Vavasour JD; Mackay AL; Li DK
    Mult Scler; 2010 Jun; 16(6):670-7. PubMed ID: 20558500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
    Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
    Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurodegeneration in the Spinal Ventral Horn Prior to Motor Impairment in Cervical Spondylotic Myelopathy.
    Grabher P; Mohammadi S; David G; Freund P
    J Neurotrauma; 2017 Aug; 34(15):2329-2334. PubMed ID: 28462691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.
    Zackowski KM; Smith SA; Reich DS; Gordon-Lipkin E; Chodkowski BA; Sambandan DR; Shteyman M; Bastian AJ; van Zijl PC; Calabresi PA
    Brain; 2009 May; 132(Pt 5):1200-9. PubMed ID: 19297508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.